|Title||Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models.|
|Publication Type||Journal Article|
|Year of Publication||2021|
|Authors||CC Kennedy, EE Brown, NO Abutaleb, and GA Truskey|
|Journal||Frontiers in Cardiovascular Medicine|
The vascular endothelium is present in all organs and blood vessels, facilitates the exchange of nutrients and waste throughout different organ systems in the body, and sets the tone for healthy vessel function. Mechanosensitive in nature, the endothelium responds to the magnitude and temporal waveform of shear stress in the vessels. Endothelial dysfunction can lead to atherosclerosis and other diseases. Modeling endothelial function and dysfunction in organ systems <i>in vitro</i>, such as the blood-brain barrier and tissue-engineered blood vessels, requires sourcing endothelial cells (ECs) for these biomedical engineering applications. It can be difficult to source primary, easily renewable ECs that possess the function or dysfunction in question. In contrast, human pluripotent stem cells (hPSCs) can be sourced from donors of interest and renewed almost indefinitely. In this review, we highlight how knowledge of vascular EC development <i>in vivo</i> is used to differentiate induced pluripotent stem cells (iPSC) into ECs. We then describe how iPSC-derived ECs are being used currently in <i>in vitro</i> models of organ function and disease and <i>in vivo</i> applications.
|Short Title||Frontiers in Cardiovascular Medicine|